EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Pharmacokinetics of GS ‐441524 following intravenous remdesivir in six cats and results of therapeutic drug monitoring during treatment of feline infectious peritonitis: 22 cases (2021–2024)

S J Coggins iD, M Govendir, J M Norris, R Malik, E J Hall, M F Thompson, B Kimble

Journal of Small Animal Practice · 2025-07 · 66 (7) · 495-506

DOI: 10.1111/jsap.13849 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Small Animal Practice, online erschienen am 17.03.2025. Verfasst von S J Coggins und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Science, Sydney School of Veterinary Science, The University of Sydney, Sydney, New South Wales, Australia. Hauptthemen laut MEDLINE: Feline Infectious Peritonitis, Adenosine Monophosphate, Antiviral Agents, Alanine. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lionel Marcellus Lonsdale scholarship, EveryCat Health Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

This study aimed to: (1) characterise the pharmacokinetics of GS‐441524 following intravenous (iv) administration of 15 mg/kg remdesivir (RDV) in client‐owned cats with feline infectious peritonitis (FIP); (2) document plasma protein binding of GS‐441524 in cats; (3) determine whether trough GS‐441524 plasma concentrations predict ‘simple remission’ or survival to 18 months; (4) measure GS‐441524 concentration in effusions relative to plasma; and (5) qualitatively assess excretion of GS‐441524 in urine. Materials and Methods Six cats with FIP were administered 15 mg/kg iv RDV. Serial plasma GS‐441524 concentrations were measured using high‐performance liquid chromatography (HPLC). Twenty‐two cats with FIP had trough plasma concentrations monitored over a 12‐week treatment period. Simultaneous effusion and plasma GS‐441524 concentrations were compared, and urine was assessed for GS‐441524 excretion.

Results

The mean peak plasma concentration of GS‐441524 ( C max ) after a single 15 mg/kg iv dose of RDV was 2632 ng/mL (SD 862); time to reach C max ( T max ) was 1 hour (SD 0); and elimination half‐life ( t 1/2 ) was 5.14 hours (SD 0.81). GS‐441524 was present in effusions ( n = 3 cats) and eliminated in urine following treatment ( n = 6 cats). Assessment of the predictive relationship between median GS TC and achieving ‘simple remission’ failed to demonstrate a significant correlation. Clinical Significance This study supports the use of RDV and GS‐441524 for FIP treatment and suggests that population pharmacokinetic modelling is required to better explore the utility of therapeutic drug monitoring of GS‐441524.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Feline Infectious PeritonitisAdenosine MonophosphateAntiviral AgentsAlanineAnimalsCatsMaleFemaleDrug MonitoringAdministration, IntravenousAdenosineAdenosine Triphosphate

Substanzen

remdesivirAdenosine MonophosphateGS-441524Antiviral AgentsGS-441524 triphosphateAlanineAdenosineAdenosine Triphosphate

Autor:innen und Institutionen

  • Faculty of Science, Sydney School of Veterinary Science, The University of Sydney, Sydney, New South Wales, Australia.
  • Centre for Veterinary Education, The University of Sydney, Sydney, New South Wales, Australia.

ORCID-Profile: S J Coggins

Förderung

  • Lionel Marcellus Lonsdale scholarship
  • EveryCat Health Foundation

Zitieren

APA

Coggins, S. J., Govendir, M., Norris, J. M., Malik, R., Hall, E. J., Thompson, M. F., & Kimble, B. (2025). Pharmacokinetics of GS ‐441524 following intravenous remdesivir in six cats and results of therapeutic drug monitoring during treatment of feline infectious peritonitis: 22 cases (2021–2024). Journal of Small Animal Practice, 66(7), 495-506. https://doi.org/10.1111/jsap.13849

Vancouver

Coggins SJ, Govendir M, Norris JM, Malik R, Hall EJ, Thompson MF, et al. Pharmacokinetics of GS ‐441524 following intravenous remdesivir in six cats and results of therapeutic drug monitoring during treatment of feline infectious peritonitis: 22 cases (2021–2024). Journal of Small Animal Practice. 2025;66(7):495-506. doi:10.1111/jsap.13849

BibTeX
@article{Coggins2025,
  author = {Coggins, S J and Govendir, M and Norris, J M and Malik, R and Hall, E J and Thompson, M F and Kimble, B},
  title = {Pharmacokinetics of GS ‐441524 following intravenous remdesivir in six cats and results of therapeutic drug monitoring during treatment of feline infectious peritonitis: 22 cases (2021–2024)},
  journal = {Journal of Small Animal Practice},
  year = {2025},
  volume = {66},
  number = {7},
  pages = {495--506},
  doi = {10.1111/jsap.13849}
}
Kostenlos starten →